Filter posts

BIO Celebrates 300 Biotech IPOs since Enactment of the JOBS Act

The biotech industry recently realized its 300th IPO since the Jumpstart Our Business Startups (JOBS) …

New Member Benefit: Online Marketplace for Custom Scientific Research Services and Products

BIO’s member companies in the pharmaceutical, life sciences, chemicals, and biotechnology sectors routinely and strategically …

#MakeHistory: Highlighting History I China

Venture capital investment in US biotech companies has skyrocketed as Chinese investors continue to fuel …

Director of USPTO Addressed Intellectual Property Track Opening Plenary

This afternoon USPTO Director Andrei Iancu delivered remarks at the BIO International Convention’s Intellectual Property Track …

New Study Shows Strong Interest in China Partnerships

A new report suggests that biopharmaceutical companies are expressing strong interest in the Chinese marketplace. …

Give Your Business Development Skills a Boost Before #BIO2018!

There is no better place to make the connections you need to secure licensing, investment …

You’re Invited: BIO Board Member to Discuss Challenges Facing Emerging Biotechs – and How to Fix...

Next week, MaxCyte CEO and Biotechnology Innovation Organization (BIO) Board Member Doug Doerfler will speak …

Don't Leave the Highly Prevalent Chronic Diseases Behind

There is a lot to be excited about in biotech right now as we are …

#MakeHistory: Highlighting History | Hong Kong’s New Listing Regime

Recent announcements that the Hong Kong Stock Exchange (HKEX) plans to allow the listing of …

Jim Greenwood Celebrates JOBS Act Turning Five (Op-Ed in The Hill)

Five years ago today, the Jumpstart Our Business Startups (JOBS) Act became law. The JOBS …